GlassScriptPhysician profile
William S Gonte
NPI 1043314164
$5,593.10
in general payments reported to CMS, 2019-2025
38 companies · $479 in 2025
The $479 reported for 2025 was more than what 85% of Sports Medicine (Internal Medicine) providers received nationally (typical 2025 total: $99.49).
See the full distribution for Sports Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $913 · 2020: $849 · 2021: $828 · 2022: $720 · 2023: $798 · 2024: $1,006 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,283.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $732.18 | 2019-2025 | Breztri, Airsupra |
| Lilly USA, LLC | $640.37 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Janssen Pharmaceuticals, INC | $529.30 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $521.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $448.61 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Merck Sharp & Dohme LLC | $281.47 | 2019-2025 | Verquvo, Gardasil 9, Gardasil |
| Abbvie INC. | $268.61 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $250.41 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Amarin Pharma, INC. | $197.66 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $178.72 | 2019 | |
| Sanofi-Aventis U.S. LLC | $173.01 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $164.90 | 2022-2023 | |
| Glaxosmithkline, LLC. | $131.18 | 2019-2025 | Trelegy Ellipta |
| Lundbeck LLC | $110.97 | 2024-2025 | Rexulti |
| Pfizer INC. | $101.03 | 2020-2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Gonte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.